Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP645855.RARfKTD-fYZMQ8wPIf41pc1XZG3n73E_K_hYULXRTQq8w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP645855.RARfKTD-fYZMQ8wPIf41pc1XZG3n73E_K_hYULXRTQq8w130_assertion type Assertion NP645855.RARfKTD-fYZMQ8wPIf41pc1XZG3n73E_K_hYULXRTQq8w130_head.
- NP645855.RARfKTD-fYZMQ8wPIf41pc1XZG3n73E_K_hYULXRTQq8w130_assertion description "[New, highly selective inhibitors of BRAF and MEK1/2 have shown promise in clinical trials, including in previously intractable diseases such as melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645855.RARfKTD-fYZMQ8wPIf41pc1XZG3n73E_K_hYULXRTQq8w130_provenance.
- NP645855.RARfKTD-fYZMQ8wPIf41pc1XZG3n73E_K_hYULXRTQq8w130_assertion evidence source_evidence_literature NP645855.RARfKTD-fYZMQ8wPIf41pc1XZG3n73E_K_hYULXRTQq8w130_provenance.
- NP645855.RARfKTD-fYZMQ8wPIf41pc1XZG3n73E_K_hYULXRTQq8w130_assertion SIO_000772 22562245 NP645855.RARfKTD-fYZMQ8wPIf41pc1XZG3n73E_K_hYULXRTQq8w130_provenance.
- NP645855.RARfKTD-fYZMQ8wPIf41pc1XZG3n73E_K_hYULXRTQq8w130_assertion wasDerivedFrom befree-20150227 NP645855.RARfKTD-fYZMQ8wPIf41pc1XZG3n73E_K_hYULXRTQq8w130_provenance.
- NP645855.RARfKTD-fYZMQ8wPIf41pc1XZG3n73E_K_hYULXRTQq8w130_assertion wasGeneratedBy ECO_0000203 NP645855.RARfKTD-fYZMQ8wPIf41pc1XZG3n73E_K_hYULXRTQq8w130_provenance.